- |||||||||| Biomarker, Trial completion, Enrollment change, Trial primary completion date: Extracellular Signal-Related Kinase Biomarker Development in Autism (clinicaltrials.gov) - Apr 19, 2017
P=N/A, N=213, Completed, Recruiting --> Completed | N=200 --> 100 | Trial primary completion date: Jul 2012 --> Jun 2013 Recruiting --> Completed | N=288 --> 213 | Trial primary completion date: Feb 2015 --> Aug 2015
- |||||||||| aripiprazole / Generic mfg.
Trial primary completion date: Aripiprazole in Children With Autism: A Pilot Study (clinicaltrials.gov) - Mar 29, 2017 P2, N=11, Completed, Suspended --> Recruiting | N=15 --> 60 Trial primary completion date: Dec 2008 --> Nov 2011
- |||||||||| Enrollment closed, Trial primary completion date: Neurofeedback Therapy for Children Diagnosed With Autism (clinicaltrials.gov) - Mar 28, 2017
P=N/A, N=64, Active, not recruiting, Phase classification: P4 --> P=N/A Recruiting --> Active, not recruiting | Trial primary completion date: May 2017 --> Sep 2017
- |||||||||| Trial completion, Enrollment change, Trial primary completion date: Early Detection of Autism Spectrum Disorder in Children (clinicaltrials.gov) - Mar 6, 2017
P=N/A, N=37, Completed, Not yet recruiting --> Recruiting | Phase classification: P2 --> PN/A | Initiation date: Mar 2016 --> Mar 2017 Active, not recruiting --> Completed | N=50 --> 37 | Trial primary completion date: Dec 2016 --> Dec 2015
- |||||||||| clonidine extended release / Generic mfg.
Enrollment change, Trial withdrawal, Trial primary completion date: Clonidine for Sleep Disturbances in Children With Autism Spectrum Disorder (clinicaltrials.gov) - Feb 2, 2017 P2, N=0, Withdrawn, Not yet recruiting --> Recruiting N=16 --> 0 | Not yet recruiting --> Withdrawn | Trial primary completion date: Jul 2017 --> Jan 2017
- |||||||||| Enrollment closed, Trial primary completion date: An Exploratory, Double-Blind, Placebo-Controlled Study of the Medical Food Vayarin in Children With Autism Spectrum Disorder (ASD) (clinicaltrials.gov) - Jan 18, 2017
P=N/A, N=56, Active, not recruiting, Active, not recruiting --> Completed Recruiting --> Active, not recruiting | Trial primary completion date: Dec 2016 --> Mar 2017
- |||||||||| Trial primary completion date: Treatment of Feeding Problems in Children With Autism (clinicaltrials.gov) - Jan 5, 2017
P=N/A, N=50, Recruiting, Recruiting --> Completed | N=155 --> 48 | Trial primary completion date: Dec 2015 --> Oct 2016 Trial primary completion date: Jan 2017 --> Jan 2018
- |||||||||| Trial completion: Comparison of DSM-IV-TR and DSM-5 for ASD (clinicaltrials.gov) - Dec 29, 2016
P=N/A, N=450, Completed, Trial primary completion date: Jan 2017 --> Jan 2018 Active, not recruiting --> Completed
- |||||||||| Enrollment closed, Trial primary completion date: A Study of the Elopement Prevention and Safety Training Program (clinicaltrials.gov) - Dec 8, 2016
P=N/A, N=24, Active, not recruiting, N=120 --> 300 | Trial primary completion date: Apr 2014 --> May 2018 Recruiting --> Active, not recruiting | Trial primary completion date: Nov 2016 --> Feb 2017
- |||||||||| Trial completion: Emergence of Generative Language (clinicaltrials.gov) - Dec 5, 2016
P=N/A, N=9, Completed, Recruiting --> Active, not recruiting | Trial primary completion date: Nov 2016 --> Feb 2017 Enrolling by invitation --> Completed
- |||||||||| Increlex (mecasermin) / Ipsen
Trial completion, Trial primary completion date: Treatment of Rett Syndrome With Recombinant Human IGF-1 (clinicaltrials.gov) - Dec 1, 2016 P2, N=30, Completed, Enrolling by invitation --> Completed Recruiting --> Completed | Trial primary completion date: Mar 2016 --> Jul 2016
- |||||||||| Enrollment closed: Comparison of DSM-IV-TR and DSM-5 for ASD (clinicaltrials.gov) - Nov 2, 2016
P=N/A, N=450, Active, not recruiting, Recruiting --> Completed | N=60 --> 81 Recruiting --> Active, not recruiting
|